A founder-led B2B business owner tells you the same story almost every time. The deal looked locked. Good chemistry with the buyer, a clear fit, a verbal “we’re moving forward.” Then it goes quiet. Three weeks later it is gone, and nobody can say exactly why.
Losing deals you expected to win is not usually a sales execution problem. According to research behind The JOLT Effect by Matthew Dixon and Ted McKenna, based on an analysis of more than 2.5 million sales conversations, 40 to 60% of lost B2B deals go to “no decision,” not to a named competitor. Only around 17% are lost to a rival vendor. If your pipeline reviews keep pointing at “we lost to Competitor X,” the data says you are probably diagnosing the wrong problem.
This article breaks down where deals actually die before the final no, why more sales activity does not fix it, and how to run your own diagnosis this week. It is written for founders and MDs running $3M to $10M B2B businesses who are winning enough deals to know the offer works, but losing enough of the “sure things” to suspect something structural is broken underneath.
Key Takeaways
- Most lost B2B deals go to indecision, not competitors. Roughly 40 to 60% end in “no decision,” and only about 17% are lost to a named rival, per Dixon and McKenna’s research in The JOLT Effect.
- A buying committee for a complex B2B purchase now runs 6 to 10 people, per Gartner. If you have only convinced one of them, the deal has not actually progressed.
- B2B win rates fell from roughly 29% in 2024 to 19% in 2025, according to the Ebsta x Pavilion GTM Benchmark Report, across 655,000 tracked opportunities.
- Hiring more salespeople or running more sales training rarely fixes a losing streak, because the leak usually sits upstream, in qualification, pricing, or internal buy-in, not in the pitch itself.
What is actually happening when you lose a deal you expected to win
Losing a deal you expected to win means a prospect who showed strong buying signals, verbal commitment, or budget confirmation ultimately does not convert, and the stated reason (price, timing, a competitor) does not match the real cause. The real cause is almost always upstream of the sales conversation: a mismatch between who you are qualifying and who actually buys, a pricing structure that creates unspoken objections, or a lack of internal advocacy once your champion goes back to their own team.
Founder-led businesses feel this acutely because the founder is the closer. When a deal that felt certain falls apart, it reads as personal, which pushes the diagnosis toward “what did I say wrong” instead of “what was broken before I ever got on the call.”
The four places revenue actually leaks before you hear no
1. Your ICP is wrong at the point of qualification
A prospect can look like a perfect fit on paper (right industry, right revenue band, right title) and still be the wrong buyer if they lack the internal authority, urgency, or budget flexibility to move. This is the single most common cause of deals that “should have closed.”
BIB’s own diagnostic work has surfaced this repeatedly, documented among the client revenue acceleration results from past engagements. In one portfolio company engagement, a sales team’s conversion rate had dropped from 40% to 25%. The cause was not a weaker pitch or a less capable team. It was a pipeline being filled with prospects who matched the demographic profile but not the buying-readiness profile. Once the qualification criteria were rebuilt around actual buying behavior rather than firmographic fit, the same team, using the same product, brought conversion back above the original 40% baseline.
2. Your pricing structure creates silent objections
Buyers rarely say “your price confused me.” They say “we need more time” or “we’re reviewing budget,” and then go quiet. A pricing structure that forces a prospect to justify cost internally without a clear framework for doing so creates exactly this kind of silent stall.
This connects directly to the status quo data above. If a buyer cannot cleanly explain to their own finance team why this specific investment, at this specific price, solves a specific and urgent problem, the path of least resistance is to do nothing. You do not lose that deal to a competitor. You lose it to inertia.
3. Nobody in the buying committee is selling for you internally
Harvard Business Review’s research on B2B buying, published in “Making the Consensus Sale,” found that today’s purchases rarely rest with a single decision maker. Instead, authority sits with a group of individuals who each hold effective veto power. Gartner’s research puts the typical buying group for a complex B2B solution at 6 to 10 people.
If your champion is convinced but has not been equipped to make the internal case, the deal stalls the moment they step back into their own organization. You were never in the room for the conversation that actually killed it.
4. You are answering “why us” instead of “why now”
A founder who has built genuine differentiation often over-invests in proving “why us” and under-invests in proving “why now.” A prospect can fully agree you are the better option and still not move, because nothing in the deal creates urgency against the default option of staying exactly where they are.
If your pipeline reviews keep landing on “we lost to a competitor” but you cannot name a specific reason you lost, the real leak is probably upstream of your sales process entirely. The Revenue Acceleration Diagnostic is a PE-grade commercial audit that identifies exactly where revenue is leaking in your business and blueprints the fixes.
What founders try instead, and why it does not fix anything
The instinct when win rates slip is to add effort. Hire another salesperson. Run a sales training. Offer a discount to get deals over the line faster. Each of these treats the symptom at the point of the sales conversation, while the actual leak sits earlier in the process.
Hiring more salespeople did not fix your revenue problem if the new hires are working the same broken qualification criteria as the old team. You now have more people losing the same deals for the same reasons, at higher payroll cost.
Sales training addresses skill, but a losing streak caused by weak ICP fit or unclear pricing will not respond to better objection handling, because the objection being handled is not the real one. The real objection was never voiced.
Discounting to close a stalling deal treats price as the barrier when the barrier is unresolved internal consensus or unclear urgency. A discount does not create urgency or build internal advocacy. It just makes the eventual “no decision” cheaper for the prospect to arrive at, and it trains your pipeline to expect a discount every time.
“Sell them what they want, give them what they need” is the principle behind Phil Pelucha’s methodology, and it applies directly here. A founder losing deals wants a better close rate. What the business actually needs is a diagnosis of where, before the close, the deal was already lost.
How to diagnose your own win rate problem
Run this against your last 10 to 15 closed-lost deals before assuming the cause:
- Pull the real reason, not the stated reason. Look past “went with a competitor” or “bad timing” in your CRM notes. Check whether a competitor was actually named in any call or email. If not, log it as a probable no-decision loss.
- Map who else was in the buying committee. For each lost deal, identify how many stakeholders you had direct contact with versus how many likely had veto power. A gap here points to a champion-enablement problem, not a pitch problem.
- Check where the deal stalled on the calendar. Deals that go quiet immediately after a proposal or pricing conversation point to a pricing-structure issue. Deals that stall after an internal “we love it, let us circle back” point to a consensus-building gap.
- Compare closed-won and closed-lost ICP profiles. If your losses cluster around a specific revenue band, industry, or buyer title that looks identical to your wins on paper, the qualification criteria are missing a variable, usually buying urgency or budget authority.
- Ask what would have made the deal urgent. For each loss, write one sentence on what specific event or cost would have made staying with the status quo more expensive than moving forward. If you cannot write that sentence, the deal likely never had real urgency behind it.
This is not a replacement for a full commercial audit, but it will tell you within an afternoon whether your losing streak is a pitch problem or an architecture problem. In BIB’s experience, it is architecture more often than founders expect.
Frequently Asked Questions
Why do I keep losing deals I thought I would win?
Deals that looked certain usually fail for reasons that never surfaced during the sales conversation: the buyer lacked internal authority to act, the pricing created an unspoken objection, or nobody inside the buying committee carried the case forward after your champion went quiet. The stated reason on your CRM record is rarely the real one.
Is losing deals a sales problem or a pricing problem?
It is rarely just one or the other. A stalled or lost deal is most often a qualification or consensus-building problem that surfaces as a pricing objection late in the process. Fixing the pitch or discounting the price treats a symptom that appears just before the loss, not the cause that created it weeks earlier.
What is a good B2B win rate?
Recent benchmarks put average B2B win rates around 19 to 21%, down from roughly 29% the prior year, according to the 2025 Ebsta x Pavilion GTM Benchmark Report covering 655,000 opportunities. Win rate varies sharply by deal size, with smaller deals closing at higher rates than enterprise deals over $100,000. A rate below your own historical average, not an industry number, is the more useful signal to track.
How many people are actually involved in a B2B buying decision?
Gartner’s research puts the typical buying group for a complex B2B purchase at 6 to 10 people, each carrying independent research and effective veto power. If you have built strong rapport with one stakeholder but never engaged the rest of that group, the deal has not progressed as far as it feels.
Conclusion
Losing deals you expected to win almost always traces back to something that happened before the final conversation: who you qualified in, how the price was framed, and whether anyone inside the buying committee was equipped to carry the case forward without you in the room. More sales effort will not fix a leak that sits upstream of the sales conversation. A diagnosis will.
Take the Next Step
If your pipeline keeps producing deals that look won right up until they are not, the fix starts with finding out exactly where in your commercial process that certainty breaks down. The Revenue Acceleration Diagnostic is a full commercial audit that maps your qualification criteria, pricing structure, and buying-committee gaps against your actual closed-lost data, and hands you a 45-page roadmap for closing the leak.
